Ventyx Biosciences, Inc. (VTYX) Financials
Stock symbol VTYX is outdated, potentially delisted? Maybe it is available on other exchange?
VTYX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 277.7 million | 33.8 million |
| Sept. 30, 2023 | 321.7 million | 38.1 million |
| June 30, 2023 | 348.8 million | 21.0 million |
| March 31, 2023 | 389.2 million | 17.6 million |
VTYX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -51.9 million | 6.1 million |
| Sept. 30, 2023 | -34.7 million | 8.0 million |
| June 30, 2023 | -49.5 million | 7.9 million |
| March 31, 2023 | -31.0 million | 6.6 million |
VTYX Net Income
No data available :(
VTYX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 252.2 million | - | 12.5 million |
| Sept. 30, 2023 | 300.8 million | - | 12.3 million |
| June 30, 2023 | 332.3 million | - | 1.4 million |
| March 31, 2023 | 376.9 million | - | 1.5 million |
VTYX Shares Outstanding
VTYX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 211000 | 40.3 million | 8.3 million | -903000 |
| Sept. 30, 2023 | 48000 | 49.8 million | 8.2 million | - |
| June 30, 2023 | 195000 | 48.6 million | 8.6 million | - |
| March 31, 2023 | 60000 | 35.4 million | 7.1 million | - |
VTYX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 403000 |
| Sept. 30, 2023 | - | 265000 |
| June 30, 2023 | - | 139000 |
| March 31, 2023 | - | 134000 |
VTYX
Price: $14
52 week price:
Earnings Per Share: -1.49 USD
P/E Ratio: -9.40
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.2 million
Market Capitalization: 1.0 billion